Disulfides

CD4 molecule ; Homo sapiens







37 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34020817 A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation. 2021 Jun 8 1
2 30429345 Conformational Differences between Functional Human Immunodeficiency Virus Envelope Glycoprotein Trimers and Stabilized Soluble Trimers. 2019 Feb 1 1
3 29470989 Redox exchange of the disulfides of human two-domain CD4 regulates the conformational dynamics of each domain, providing insight into its mechanisms of control. 2018 Mar 4 3
4 26860867 New Approach for Inhibition of HIV Entry: Modifying CD4 Binding Sites by Thiolated Pyrimidine Derivatives. 2016 Jul 1
5 27009680 Human CD4 Metastability Is a Function of the Allosteric Disulfide Bond in Domain 2. 2016 Apr 19 9
6 27041594 Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region. 2016 May 3 1
7 27233453 Thioredoxin (Trx1) regulates CD4 membrane domain localization and is required for efficient CD4-dependent HIV-1 entry. 2016 Sep 1
8 25944298 Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120. 2015 Jun 9 1
9 26690492 Discovery of a Natural Defense Against HIV With Therapeutic Potential. 2015 Oct-Dec 1
10 26719252 Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers. 2015 Dec 30 2
11 24257748 CD4 and BST-2/tetherin proteins retro-translocate from endoplasmic reticulum to cytosol as partially folded and multimeric molecules. 2014 Jan 3 2
12 25299596 Probing the effect of force on HIV-1 receptor CD4. 2014 Oct 28 2
13 24146829 Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein. 2013 4
14 22291921 Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein. 2012 1
15 20538591 Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange. 2010 Aug 13 11
16 20943653 Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin. 2010 Dec 17 6
17 20974843 Reduced monomeric CD4 is the preferred receptor for HIV. 2010 Dec 24 1
18 19038358 Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication. 2009 Jun 3
19 19018669 High-affinity binding of southern African HIV type 1 subtype C envelope protein, gp120, to the CCR5 coreceptor. 2008 Dec 1
20 16480776 Molecular cloning and sequencing of the cDNA encoding the bat CD4. 2006 Jun 15 1
21 16507315 Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion. 2006 Jul 5 3
22 16519733 Marked differences in the structures and protein associations of lymphocyte and monocyte CD4: resolution of a novel CD4 isoform. 2006 Apr 2
23 16633351 Site-specific PEGylation of native disulfide bonds in therapeutic proteins. 2006 Jun 1
24 16709847 Evidence for a domain-swapped CD4 dimer as the coreceptor for binding to class II MHC. 2006 Jun 1 6
25 15322779 Cloning, expression, and characterization of fugu CD4, the first ectothermic animal CD4. 2004 Aug 1
26 12218052 Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. 2003 Jan 31 1
27 12897445 Disulfide exchange in CD4. 2003 1
28 12089508 Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. 2002 Aug 2
29 12218051 Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. 2002 Dec 27 4
30 8707860 Intracellular location of cysteine transport activity correlates with productive processing of antigen disulfide. 1996 Aug 1
31 8554907 Alanine substitution of two arginines in amino terminus of V3 of SIV disrupts CD4 binding whereas a similar replacement of two amino acids, lysine and arginine, in the carboxyl half of V3 prevents binding of a neutralizing monoclonal antibody. 1995 Sep 1
32 1985197 Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. 1991 Jan 1
33 2494662 Molecular heterogeneity of gamma delta T-cell antigen receptors expressed by CD4- CD8- T-cell clones from normal donors: both disulfide- and non-disulfide-linked receptors are delta TCS1+. 1989 Apr 1
34 2513572 CD4 and CD8 molecules can physically associate with the same T-cell receptor. 1989 Dec 1
35 2558637 Cystein 402 of HIV gp 120 is essential for CD4-binding and resistance of gp 120 to intracellular degradation. 1989 1
36 2453925 Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. 1988 Jun 3 1
37 3104900 Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. 1987 Mar 1